More about Manoj Kumar, PhD
Innovative biomedical scientist specializing in CRISPR/Cas based genetic engineering with a focus on single nucleotide precision variant detection. Pioneered the development of the FnCas9 Editor Linked Uniform Detection Assay (FELUDA), a groundbreaking low-cost SARS-CoV-2 detection test, and the Rapid Variant Assay (RAY) for robust diagnosis of monogenic and infectious disorders. Currently exploring novel applications of CRISPR/Cas9 technology, including the concept of the CRISPR/Cas9 Utilizing Human Body Sticker (CRISticker) for visually identifying pathogenic variants in a sequencing-free manner. Excited about leveraging multiplexable assays to advance clinical research, disease genotyping, microbial infection surveillance, food safety, and industrial biotechnology.
Featured speakers at eChai events
Preferred eChai Business Partners
The eChai Preferred Business Partners program enables businesses more visibility within the eChai Network through an annual subscription.
About eChai Business Partner Program:
Key benefits:
- Listing on preferred eChai Business Partners page (1 year duration)
- Engagement at relevant in-person eChai Meetups (~4 meetups/year)
- Feature on eChai.Ventures
eChai Ventures is a friendly global startup network that hosts engaging Startup Growth meetups in 10+ Countries and enables cross-border collaborations.
You can reach out to Jatin Chaudhary, Co-Founder, eChai Ventures over WhatsApp or over email at [email protected] to explore more about it.